enGene Therapeutics Inc. (ENGN): 8-K filed Sep 8, 2026

Form type

8-K

Filing date

Sep 8, 2026

Accession number

0001193125-26-384380

Filer

enGene Therapeutics Inc. (CIK 1980845)